Skip to Main Content


Skip Nav Destination

Abstract CT112: Exposure-response analysis of pembrolizumab in patients with advanced melanoma and non-small cell lung cancer enrolled in KEYNOTE-001, -002, and -006

Cancer Res (2016) 76 (14_Supplement): CT112.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal